Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN
Clinical trial NCT03085719 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03085719
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-30
- Primary completion
- 2022-11-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.